Tweetovi

Blokirali ste korisnika/cu @Indivumed1

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Indivumed1

  1. prije 17 sati

    Thank you to for sharing the launch of our 2nd partnership w/ . We are excited to move forward, make new discoveries, & develop novel drug treatments for NSCLC as a result of our collaboration. Together we are going .

    Poništi
  2. 4. velj

    World Cancer Day is a global uniting initiative to raise awareness, educate, and catalyze personal and government action. For the Indivumed team, our commitment to developing personalized medicine for cancer remains stronger than ever.

    Poništi
  3. 4. velj

    A big thank you to for sharing news of our 2nd partnership with . Together, we hope to make great strides in the discovery and treatment of non-small cell lung cancer.

    Poništi
  4. proslijedio/la je Tweet
    23. sij

    Evotec and enter into new research collaboration to discover and develop first-in-class therapeutics to treat non-small cell lung cancer. Read the press release here

    Poništi
  5. 23. sij

    We are excited to announce a 2nd joint program with through 2020. Our goal is to replicate the successful milestone achievement from our Revolutionary Joint Drug Discovery Program in Colorectal Cancer.

    Poništi
  6. 14. sij

    We are excited to announce our partnership w/ and the expansion of the IndivuType global cancer database in Italy. As a result of this collaboration, we hope to advance the field of personalized medicine for cancer. Learn more:

    Poništi
  7. 14. sij

    Don't miss Fernando Andreu's and Alexander Hergovich's session on how the relationship between multiomics, AI, and ML can advance novel cancer discoveries at this year's Precision Medicine World Conference.

    Poništi
  8. 10. sij

    Indivumed's Chief Business Officer, Fernando Andreu, and Evotec's Principal Scientist, Alex Hergovich, will be speaking at PMWC 2020. Learn more about their session, 'Unveiling Cancer Biology Through Multiomics':

    Poništi
  9. 7. sij

    We're starting off the year by preparing for PMWC 2020. This year, Indivumed's Fernando Andreu and Evotec's Alexander Hergovich will be speaking on the 'Unveiling Cancer Biology Through Multiomics' session. Learn more:

    Poništi
  10. 3. sij

    We are looking forward to a year of continued progress in revolutionizing cancer treatment through individualized therapy. Learn more about our work:

    Poništi
  11. 25. pro 2019.

    The Indivumed team wishes you happy holidays and a prosperous 2020.

    Poništi
  12. 23. pro 2019.

    To our team, our partners, and our families - we wish you the happiest of holidays and are looking forward to a prosperous new year.

    Poništi
  13. 18. pro 2019.

    We are excited to host attendees at our session, 'Unveiling Cancer Biology Through Multiomics' with Fernando Andreu, Indivumed's Chief Business Officer, and Evotec's Principal Scientist, Alex Hergovich.

    Poništi
  14. 13. pro 2019.

    Don’t miss our Precision Medicine World Conference session by Fernando Andreu, 'Unveiling cancer biology through multiomics'. Learn more about this session:

    Poništi
  15. 10. pro 2019.

    We are proud to have made great progress in 2019, and hope this new year is full of even bigger strides towards reaching our goals in the field of precision . Learn more about our goals and how we are working to achieve them:

    Poništi
  16. 6. pro 2019.

    Thank you to all who attended this year's BioData World Congress. We had a great time meeting industry professionals and learning more about their contributions to the field.

    Poništi
  17. 2. pro 2019.

    Follow the Big Data and Oncology track and listen to Indivumed's data scientist, Jonathan Woodsmith, share his expertise at this year's BioData World Congress - tag in your social posts!

    Poništi
  18. 2. pro 2019.

    We are excited to announce our partnership with , a leader in next generation proteomics solutions. This partnership represents the next step in enabling novel discoveries in cancer biology. Learn more about our partnership:

    Poništi
  19. 29. stu 2019.

    Our team will be there. Meet with Hans Vanhooren & Carlos Martinez for Business Development discussions & Roald Forsberg & Jonathan Woodsmith for our latest oncology informatics advances. DM us to catch up at the conference.

    Poništi
  20. 26. stu 2019.

    Our CEO, Prof. Dr. Hartmut Juhl shares his excitement for BioData World Congress. Jonathan Woodsmith, Indivumed's data scientist, will speak on the Big Data and Oncology track on December 4th at 3:30.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·